相关实验视频
Updated: May 31, 2025

07:34
Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits
Published on: June 2, 2019
9.6K
小分子Peroxiredoxin模仿者恢复生长因子信号,并逆转血管重塑
Dong Hoon Kang1, Jiran Kim1, Jiyoung Lee1
1Department of Life Science, Ewha Womans University, Seoul, 03760, Republic of Korea.
Free radical biology & medicine
|January 23, 2025
概括
新型的epidithio-diketopiperazine (ETP) 衍生物作为2-Cys peroxiredoxin (PRX) 模仿剂. 这些化合物减少过氧化,恢复血管细胞功能,并在动物模型中逆转血管封闭.
科学领域:
- 生物化学 生物化学
- 药用化学 医学化学
- 细胞生物学 细胞生物学
背景情况:
- 流行性二基托皮佩拉зин (ETP) 化合物是已知生物效应的真菌代谢物.
- 之前没有报告ETP衍生物的类似酶的催化活性.
- 2-Cys过氧化 (PRX) 是调节细胞氧化还原平衡的关键酶.
研究的目的:
- 为了产生具有过氧化物降解活性的新型ETP衍生物.
- 研究这些ETP衍生物的类似酶的催化功能.
- 探索ETP衍生物作为2-CysPRX模仿剂的治疗潜力.
主要方法:
- 核心ETP环结构的战略衍生.
- 测试与硫素/硫素还原酶和谷氨系统一起测试H2O2降解活性.
- 在体外评估ETP衍生物对血管细胞信号和功能的影响.
- 在动物血管损伤模型中测试ETP衍生物的疗效.
主要成果:
- 合成了新的ETP衍生物,表现出特定的H2O2降低活性.
- 带有小侧链的ETP衍生品作为真实的2-Cys PRX模仿剂发挥作用.
- 在缺乏2-Cys PRX的血管细胞中,ETP衍生物恢复了受体Tyr酶信号传递和细胞功能.
- 在体内,ETP模拟剂通过抑制光滑肌肉增生和促进重新内皮质化来逆转血管封闭.
结论:
- 可以设计ETP衍生物来模仿2-Cys PRX酶活性.
- 这些新型模仿剂为涉及缺陷2-Cys PRX.的疾病提供了潜在的治疗策略.
- 这项研究提出了一个新的化学平台,用于补充生物系统中的酶功能.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Mechanism of Angiogenesis
5.2K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.2K
Antihypertensive Drugs: Vasodilators
470
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
470
Role of Hematopoietic Growth Factors
1.2K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.2K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K

